Stereoselective disposition of sustained release microspheres of ibuprofen enantiomers in rats: II. Acute gastrointestinal toxicity

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 6, Issue 3, 1999, Pages 163-170

  Janjikhel, Rajiv K ^a,c   Bricker, J Douglas ^a   Borochovitz, D ^b   Adeyeye, Christianah Moji ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b MERCY HOSPITAL OF PITTSBURGH   (United States)

^c Pharmaceutics International Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETHANECHOL; IBUPROFEN; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; ENANTIOMER; ENCAPSULATION; GASTROINTESTINAL TOXICITY; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY; SUSPENSION; SUSTAINED RELEASE PREPARATION; ULCEROGENESIS;

EID: 0032873732     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/107175499266913     Document Type: Article

References (28)

1. Williams, K., Day, R., Knihinicki, R., and Duffield, A. 1986. The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochem. Pharmacol. 35:3403-3405.
2. Orme, M., Sartorelli, A. C., Bowman, W. C., and Breckenridge, A. M. (eds.) 1990. Clinical pharmacology of non-steroidal anti-inflammatory drugs, In Antirheumatic Drugs: International Encyclopedia of Pharmacology and Therapeutics, section 133, 153-161. New York: Pergamon Press.
3. Klein, G., Neff, H., Kullich, W., Phelps, W., and Kollenz, J. 1992. S-(+) versus racemic ibuprofen. Lancet 339:681.
4. Davies, N. M., Wright, M. R., Russell, A. S., and Jamali, F. 1996. Effect of enantiomers of flurbiprofen, ibuprofen, and ketoprofen on intestinal permeability. J. Pharm. Sci. 85(11):117-1173.
5. Wechter, W. J., Bigornia, A. E., Murray, Jr., E. D., Levine, B. H., and Young, J. W. 1993. Rac-flurbiprofen is more ulcerogenic than its (S)-enantiomer. Chirality 5:492-594.
6. Davies, N. M., Corrigan, B. W., and Jamali, F. 1995. Sucrose urinary excretion in the rat measured using a simple assay: A model of gastroduodenal permeability. Pharm. Res. 12(11):1733-1736.
7. Hawkey, C. J. 1996. Non-steroidal anti-inflammatory drug gastropathy-causes and treatment. Scand. J. Gastroenterol. 31(Suppl 220):124-127.
8. McGeer, P. L., and Rogers, J. 1992. Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42:447-449.
9. Breitner, J. C. S. 1996. The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Ann. Rev. Med. 47:401-411.
10. Patano, C. 1994. Aspirin as an antiplatelet drug. N. Engl. J. Med. 330:1287-1294.
11. Adeyeye, C. M., Bricker, J. D., Vilivalam, V. D., and Smith, W. I. 1996. Acute gastrointestinal toxic effects of suspensions of unencapsulated and encapsulated ibuprofen in rats. Pharm. Res. 13(5):784-793.
12. Jamali, F. 1996. Surrogate markers of gastrointestinal abnormalities: Gut permeability. Pharm. Res. 13(9-Suppl):S534.
13. Davies, N. M., Wright, M. R., and Jamali, F. 1994. Anti-inflammatory drug-induced small intestinal permeability: The rat is a suitable model. Pharm. Res. 11(11):1652-1656.
14. Janjikhel, R. K., and Adeyeye, C. M. 1997. Stereospecific formulation and characterization of sustained release ibuprofen microspheres. J. Microencapsul. 14(4):409-426.
15. Adeyeye, C. M., and Price, J. C. 1994. Development and evaluation of sustained release ibuprofen was microspheres. I. Effect of formulation variables on physical characteristics. Pharm. Res. 11(4):575-579.
16. Rainsford, K. D. 1937. Gastric ulcerogenicity of nonsteroidal anti-inflammatory drugs in mice with mucosa sensitized by cholinomimetic treatment. J. Pharm. Pharmacol. 39:669-672.
17. Adeyeye, C. M., and Chen, F. 1997. Stereoselective disposition of suspensions of conventional and wax-matrix sustained release ibuprofen microspheres in rats. Pharm. Res. 14(12):1810-1815.
18. Wright, M. R., Sattari, S., Brocks, D. R., and Jamali, F. 1992. Improved HPLC assay method for the enantiomers of ibuprofen. J. Chromatogr. 583:259-265.
19. Lemko, C. H., Caille, G., and Foster, R. T. 1993. Stereospecific high-performance liquid chromatography assay of ibuprofen: Improved sensitivity and sample processing efficiency. J. Chromatogr. 619:330-335.
20. Janjikhel, R. K., and Adeyeye, C. M. (19). Stereoselective disposition of ibuprofen enantiomer sustained release microspheres in rat. I. Bioavailability Considerations. Drug Delivery, submitted.
21. Wallace, J. L. 1997. Non-steroidal anti-inflammatory drugs and gastroen- teropathy: The second hundred years. Gastroenterology 112:1000-1016.
22. Hutt, A. J., and Caldwell, J. 1983. The metabolic chiral inversion of 2-arylpropionic acids-a novel route with pharmacological consequences. J. Pharm. Pharmacol. 35:693-704.
23. Bjarnason, I., Fehilly, B., Smethurst, P., Menzies, I. S., and Levi, A. J. 1991. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 32:275-277.
24. Reuter, B. K., Davies, N. M., and Wallace, J. L. 1997. Nonsteroidal anti-inflammatory drug enteropathy in rats: Role of permeability, bacteria, and enterohepatic circulation. Gastroenterology 112:109-117.
25. Wax, J., Clinger, W. A., Varner, P., Bass, P., and Winder, C. V. 1970. Relationship of the enterohepatic cycle to ulcerogenesis in the small rat bowel with flufenamic acid. Gastroenterology 58(6):772-780.
26. Wallace, J. L., and Granger, D. N. 1992. Pathogenesis of NSAID gastropathy: Are neutrophils the culprits? Trends in Pharmacol. Sci. 13 (April): 129-131.
27. Jenkins, A. P., Trew, D. R., Crump, B. J., Nukajam, W. S., Foley, J. A., Menzies, I. S., and Creamer, B. 1991. Dp non-steroidal anti-inflammatory drugs increase colonic permeability? Cut 32:66-69.
28. Bjarnason, I., Hayllar, J., MacPherson, A. J., and Russell, A. J. 1993. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 104:1832-1847.